chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I've had recurring hives daily that started roughly a week after the booster.  They are all over my body, wax and wane throughout the day.  They generally are pretty itchy.  Presents as dermatographia. I've never had hives before. It's been about 8 weeks and it hasn't yet gotten better.  A friend who is an allergist suggested it is related to the booster and that he's been seeing similar cases professionally, so I'm reporting it.
Had muscular pain in pelvic area and in back.   Had to take Tylenol for pain.  Lasted all day but gone today, Thursday March 18, 2021.  I feel fine today.
2 vials were punctured 28 times each, 8 time more than the 20 puncture advised; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (2 vials were punctured 28 times each, 8 time more than the 20 puncture advised) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039D21A) for COVID-19 vaccination.     No Medical History information was reported.    In October 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (2 vials were punctured 28 times each, 8 time more than the 20 puncture advised). In October 2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (2 vials were punctured 28 times each, 8 time more than the 20 puncture advised) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products were reported.  No treatment drugs were reported.  Reporter stated that vials were punctured 28 times each, 8 time more than the 20 puncture advised, on 10/22/2021 and 10/25/2021.  No adverse events  were reported.
fairly ill; This is a spontaneous report from a non-contactable consumer. An adult patient of an unspecified gender received the 2nd dose of bnt162b2 (BNT162B2), via an unspecified route of administration, on an unspecified date, as single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The day after vaccination the patient felt fairly ill (non-serious) with outcome of recovered. It was unknown if therapeutic measures were taken.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
hypersensitivity; experience intense itching/ itching is inside of my body; urticaria extends from top of head to toes, including eyelids/welts; bumps all over; Initial information received on 28-Oct-2022 regarding an unsolicited valid  non-serious case received from a physician.  This case involves a 82 years old male patient who experienced bumps all over, hypersensitivity, experience intense itching/ itching is inside of my body and urticaria extends from top of head to toes, including eyelids/welts after receiving influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent].  The patient's past vaccination(s) included FLUZONE QUADRIVALENT. The patient's past medical history and family history were not provided. At the time of the event, the patient had ongoing Neuropathy, Demyelinating polyneuropathy and Cardiac arrhythmia.  Concomitant medications included tramadol for neuropathy and a beta-blocker for cardiac arrythmia.  On 01-Oct-2022, the patient received a  dose of suspect influenza quadrival A-B high dose HV vaccine (dose, frequency,formulation, lot number and expiry day not reported) via unknown route in unknown administration site for immunization.  On 03-OCT-2022 the patient developed bumps all over (generalised oedema), intense itching/ itching is inside of my body (pruritus) and urticaria extends from top of head to toes, including eyelids/welts (urticaria) (latency: 3 days). On an unknown date the patient developed a non-serious hypersensitivity (unknown latency). He states that he tried taking Benadryl, but that did nothing for him. Now he's taking Zyrtec, but so far that's done nothing either. Dr. states that he does have a demylinating neuropathy, and he wonders if the vaccine somehow traveled in those nerves, causing general irritation of them. He reports that there is no visible rash, the itching is "inside of my body". He states that the urticaria extends from the top of his head to his toes, including his eyelids.   Action taken: not applicable.  The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Urticaria.  At time of reporting, the outcome was Unknown for all the events.
Approximately 1:30 PM received vaccine. 6:30 PM could not stay awake - exhausted. 10:00 PM woke up by husband, LUE "like an egg" applied ice, went to bed, husband felt something wrong. 12:00 AM - aches/pain/chills/swollen eyes & face. 5:00 AM - ice pack to swollen face.
I felt fine the first 12 hours after the shot other than a little bit of brain fog.  12-36 hours after the shot, I felt terrible.  I was achy, sweaty, had chills, no appetite and two waves of nausea.  I had trouble sleeping.  I ate very little during this time (toast, banana, soup), and threw up once.  I had to rest all day.  My left arm hurt and my lymph node by my left armpit hurt.  (I have had ultrasounds  over the past couple of years of my left breast/armpit taken due to an enlarged dense lymph node discovered on a mammogram.  The ultrasounds have showed no increase in growth, and no signs of cancer.) I started feeling better 36 hours after the shot.  It's now just over 48 hours post-vaccine.  The lymph node pain remains and if I try to do anything even mildly strenuous I get flushed and tire easily, so I have been mostly resting.  This was my second shot.
extreme irritability starting 3 hrs p/vax lasting 9 hrs w/refusal to feed; rx'd APAP;
102 degree fever -7pm day of injection - dissipated after 5am Severe body aches - 7pm day of injection - lasted all night into Monday afternoon  Constantly having to urinate - since 10pm night of injection to current date - Thursday  Kidney/back pain - since 10pm night of injection  to current date - Thursday  Slight fever and body aches Tuesday night to current day - Thursday
Second vaccine gave her tennis ball sized lump on her right arm at injection site; Headache; This is a spontaneous report from a contactable consumer (patient mother). This is report 2 of 3. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection Batch/Lot number was not reported, Expiration Date was not reported), via an unspecified route of administration, administered in right arm on 16Jun2021 13:30 as 2nd dose, single for covid-19 immunization. The patient medical history included head seizure. They were so bad that caller had to learn how to do a tracheotomy and she had to learn triage. Her daughter started these at 18 months Concomitant medications were not reported.  The patient historical vaccine included first dose of BNT162B2 for COVID-19 immunization on an unspecified date and experienced headache. It was reported that, on 16Jun2021, second vaccine gave her tennis ball sized lump on her right arm at injection site and headache. she got her second vaccine and it looked like half a tennis ball on her arm from what the picture she sent her mother; clarified second vaccine gave her tennis ball sized lump on her right arm at injection site and had headache with second vaccine too, still had headache. The outcome of the event headache was not resolved and unknown for event second vaccine gave her tennis ball sized lump on her right arm at injection site.  Information about batch/lot number has been requested.
right eye began leaking and progresses; This spontaneous case was reported by a consumer and describes the occurrence of EYE DISCHARGE in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced EYE DISCHARGE. At the time of the report, EYE DISCHARGE had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was reported. Patient stated his right eye began leaking and as the week progressed, it was still leaking profusely. No treatment drug details was reported.   This case was linked to MOD-2021-436262, MOD-2021-436731 (Patient Link).
Arm swelling; Arm movement decreased; arm pain; Arm pain itchy; thigh pain; lump at the site; heat at the site; arm pain at the site of the injection; Information was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act via the Agency (VAERS # 857145).  Information has been received from a registered nurse, concerning a 15-year-old female patient with seasonal allergy and chronic kidney disease (one kidney). The patient's pertinent medical history was not provided. At the time of vaccination, the patient was not taking any concomitant therapies and no illness were present (and up to one month prior).  On 11-JAN-2020 at 10:34, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), intramuscular in the left arm, Lot # reported as 162191, at the physician's office, for prophylaxis.         On 11-JAN-2020 at 17:00, reported as the evening of the vaccine's day, the patient started with arm pain at the site of injection (vaccination site pain). Within 24 hours, the patient experienced severe pain, lump at the site (vaccination site mass), and heat at the site (vaccination site warmth). 72 hours after the shot, her thigh started with severe pain (pain in extremity) when touched but no injury was noted to that area. The left deltoid continued o be painful, hot to touch, and interfering with activity. The patient was scheduled for sick child visit on 20-JAN-2020 but since arm was much improved one week later from the onset of symptoms, follow-up appointment was cancelled. At the time of the report, the patient recovered from all the adverse events. The causality assessment between the events and suspect therapy was not provided by the reporter.    Lot Number 162191 is not valid for HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast). Lot number does not match any Company product as confirmed by Lot Verification team.  Follow up information has been received from the registered nurse on 17-FEB-2022.  The lot number of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) prefilled syringe was updated to 1621931 with expiration date on 26-JAN-2022.  Vaccine was administered in the left deltoid. The patient's concurrent conditions included chronic kidney disease stage 1. The patient was born with one kidney.   On 14-JAN-2020, the patient experienced arm swelling, decreased arm mobility, arm pain and itchiness. On 18-JAN-2020, the patient recovered from decreased arm mobility, arm pain and itchiness. She recovered on an unspecified date from arm swelling. No treatment was required for the events.  The events were considered related to hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9).
Fatigued; Some headaches; received BNT162B2 (BNT162B2, PFIZER-COVID-19 Vaccine, Solution for injection, Lot number and expiration date: Not reported), via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took BNT162B2 (BNT162B2, PFIZER-COVID-19 Vaccine, Solution for injection, Lot number and expiration date: Not reported), via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for COVID-19 immunisation. It was reported that Mom felt fatigued with some headaches but the headaches have not persisted. any visual changes, numbness, tingling, galt changes, slurred speech, headaches that wake her from sleep or cognitive changes, She has been feeling latigued daily since receiving her COVID vaccine. She denies any fever or joint pain. There has been no recent Injury. Therapeutic measures were taken as a result of some headaches. The outcome of the event headache was recovered and other event was unknown.  No Follow-up attempts are needed. No further information is expected.
We have some Moderna Covid-19 vaccine that was given after the expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-19 vaccine that was given after the expiration date) in an 81-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination.     No Medical History information was reported.   In October 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In October 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-19 vaccine that was given after the expiration date). In October 2021, EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-19 vaccine that was given after the expiration date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   4 vials were stored in refrigerator 24-Sep-2021 with no temperature excursions. Dose was given on between 24-Oct-2021 to 27-Oct-2021.  No concomitant medication was reported by reporter. No treatment medication was reported by reporter.
That Saturday, I had a headache. On Sunday, I was fatigue and had a fever. On Monday, I woke, and my throat was swollen. It was very painful. I could not talk. Around 11 am, I had a tightness in my chest. It felt like someone was squishing. I then contacted the pharmacist where I got my vaccine from. They did not answer. So, I contacted my doctor and was advice to got to the ER. At the ER they did blood work, EKG, chest x-ray, and a CT scan. They diagnosed me with Pleuritic chest pain and Coryza.
herpes zoster; Information has been received from a lawyer and a patient of unknown age regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. On or about 09-DEC-2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot# and route unknown) for the long-term prevention of shingles and zoster-related conditions. Subsequently, the patient was treated by a provider for the following injury resulting from zoster vaccine live (ZOSTAVAX): herpes zoster. The outcome of the event was unknown. The causality assessment was considered to be related by the lawyer.
NauseaVomiting, HYPERtension, L ARM HEAVINESS IMMEDIATELY AFTER VACCINE Narrative:  Continue to monitor blood pressure throughout day. BP immediately post vaccine 164/115, l arm heaviness, nausea.  Other Relevant History:
This spontaneous report was received from a registered nurse and refers to a 4 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 01-AUG-2017, the patient was vaccinated with an improperly stored PROQUAD at a dose of 0.5 (units not specified), lot # N013865 with expiry date 31-OCT-2018 (dose number, route and anatomical location not reported) for prophylaxis. Concomitant therapies included a properly stored sterile diluent (manufacturer unknown). The administered dose of vaccine was stored in the temperature between 6 degrees Fahrenheit and 14 degrees Fahrenheit for 20 hours and in the temperature between 15 degrees Fahrenheit and 46 degrees Fahrenheit for 6 hours. There were no previous temperature excursions. Data logger was involved. No adverse effects were reported. No additional information was provided. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1707USA006208:
I had a breakthrough case of Covid-19 with cold like symptoms head congestion cough and fever.
Child had fever, rash, irritability, and lack of appetite. Lasting at least 4 hours. No treatment given at this time.
Itching and sensitivity around right side breast nipple later turning into what appeared to be an open sore.  Area under breast had itching turning into red bumps and then open sores with pain.  Went to family physician on February 29, PM, and was diagnosed with Shingles.  Physician prescribed Mupirocin 2% ointment, Sulfamethoxazole-TMP DS, and Valacyclovir HCL.  Rash and pain still exist at this time however it appears to be slowing going away.
Patient received vaccination 12-Jun-04 and reported the reaction on 15-Jun-04~1400. Mild swelling and redness with prodominant heat radiating from site. Patient said that it started as a nickle size redness, when evaluated it was about 3.5 inches in diameter.  Advised patient to treat with a warm compress and check periodically for size, swelling, redness, etc.
Information has been received from a consumer concerning her 51 year old father who on 12-NOV-2007 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Suspect vaccination included influenza virus vaccine (unspecified) and tetanus toxoid. On 12-NOV-2007 the patient experienced very sore arm and flu-like symptoms. The patient's very sore arm and flu-like symptoms persisted. No further information is available.
There was an error when the Pfizer vial was diluted and less than 1.8mL of diluent was added to the vial so a higher than recommended dose was administered. Unknown exact amount of diluent added, but four 0.3mL doses were taken out of vial. Patient notified of error and side effects to monitor for.
03/11/2021 approximate date contacted primary physician who was out office, went to clinic misdiagnosed with bug bite on her face and she returned 3-4 days letter because symptoms were worsening and they referred to ER, but they assisted with appointment at Urgent Care associated with Hospital. They looked at it stated that she had shingles. Patient states that it left side of face, jaw, inside left ear, down the left side of throat and near the left eye. Put her on an antiviral for shingle medication for 10 days. Was still taking medication at time of second shot. Advised against changing her dose 2 date. The doctor who advised care and diagnosis says he had 3-4 patients already that week that developed shingles after their vaccination. That is why he was so confident and quick with his diagnosis. Patient has a remaining scar for this adverse reaction shingles. Feel fine, recovered and got Shingles vaccination and had another COVID booster, Moderna 12/2021 mild. Dose 2 was on antiviral from Shingles and still running a low grade fever.
Received request for Moderna vaccines for family member of an employee. They filled out the required forms. Employee family member filled out the form with wrong birthday. Administered shot in right deltoid. No concerns. Monitored for 15 minutes after dose. No concerns.
This spontaneous report as received from a nurse concerning an unspecified number of patients, of an unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with a dose of GARDASIL (dose, dose number, lot number, expiration date and route were not reported). Co-suspect and concomitant therapies were not reported. Doses of GARDASIL were exposed to a supported temperature excursion, that was evaluated on 10-JAN-2014 (SRN 1-10059041254) were administered to unspecified patients on unspecified dates. No adverse effect has been reported. Additional information has been requested.
For approximately six hours, fever, chills, headache, body aches.  I also had a red itchy rash on the right arm from the bicep to the forearm and, a red itchy rash on the back of both my left and right thighs.  These rashes lasted for 5-6 days.
Narrative: 61 yo male patient who received covid vaccine on 3/31/21 & 4/30/21 died of unknown causes, unknown location & unknown circumstances on 12/22/2021. It appears pt stopped coming to Facility on 4/30/2021. No notes since that date. PROMBLEM LIST: Other chronic nonalcoholic liver diseasehypertension, Essential Osteoarthritis (ICD-9-CM 715.90) Tinnitus (ICD-9-CM 388.30) Unspecified sinusitis (chronic) (ICD-9-CPainic Disorder without Agoraphobia (IDC-9-CM 300.01) HYPERLIPIDEMIA Unable to assess if this death is related to covid vaccines. Likely death is not given long timer period between date of vaccines and date of death.
Received vaccine on 12-10-13 at 4:45 PM. I was in good health 12-22-13 flu like symptoms 2-5-14 feeling better 2-6-14 hands had numbness 2-7-14 hands and feet numbness trouble walking 2-8-14 In hospital with Guillain-Barre.
FEELING LIKE DYING; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 12-APR-2021, the subject experienced feeling like dying. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of feeling like dying was not reported. This report was non-serious.
Developed skin rash on arm below injection site on arm. Red, itchy, warm to touch. About 4 inches in diameter, oval shaped. Symptoms not severe, and did not require medical attention. Cleared up after 5 days.
Severe headache, took Advil several times every 4 hours. Chills and upset stomach ache, diarrhea.
4JUN91 @ 530PM t104ax, very fussy, irritable; Would sleep for long period of time; Seen by MD- very lethargic, cont to sleep for long period of time, pale-found no source of infect said rxn to Pertussis; Gave note to mom to defer Pertussis;
1. Temperature of the fridge used to store the flu vaccine is not monitored, and the vaccine potentially may have been exposed to extreme temperatures and may have lost its potency. 2. Patient received flu vaccine that is approved for 65 yr and older. pt was 64yrs at the time of administration
Passed out with no notice, ER visit for Syncope, headache, shoulder pain, ongoing feeling of illness.